XML 54 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information (Tables)
12 Months Ended
Jun. 30, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The following table presents revenue for each reportable segment and Corporate:
(in millions)202120202019
Pharmaceutical$145,796 $137,495 $129,917 
Medical16,687 15,444 15,633 
Total segment revenue162,483 152,939 145,550 
Corporate (1)(16)(17)(16)
Total revenue$162,467 $152,922 $145,534 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue by Reportable Segment
The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:
(in millions)202120202019
Pharmaceutical Distribution and Specialty Solutions (1) (2)$144,988 $136,693 $129,067 
Nuclear and Precision Health Solutions808 802 850 
Pharmaceutical segment revenue
145,796 137,495 129,917 
Medical distribution and products (3)14,485 13,429 13,833 
Cardinal Health at-Home Solutions2,202 2,015 1,800 
Medical segment revenue
16,687 15,444 15,633 
  Total segment revenue162,483 152,939 145,550 
Corporate (4)(16)(17)(16)
Total revenue$162,467 $152,922 $145,534 
(1)Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services"
(2)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.
(3)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division
(4)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Disaggregation of Revenue [Table Text Block]
(in millions)202120202019
Pharmaceutical Distribution and Specialty Solutions (1) (2)$144,988 $136,693 $129,067 
Nuclear and Precision Health Solutions808 802 850 
Pharmaceutical segment revenue
145,796 137,495 129,917 
Medical distribution and products (3)14,485 13,429 13,833 
Cardinal Health at-Home Solutions2,202 2,015 1,800 
Medical segment revenue
16,687 15,444 15,633 
  Total segment revenue162,483 152,939 145,550 
Corporate (4)(16)(17)(16)
Total revenue$162,467 $152,922 $145,534 
(1)Products and services offered by our Specialty Solutions division are referred to as “specialty pharmaceutical products and services"
(2)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.
(3)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division
(4)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
(in millions)202120202019
United States$157,756 $148,707 $141,479 
International4,727 4,232 4,071 
Total segment revenue162,483 152,939 145,550 
Corporate (1)(16)(17)(16)
Total revenue$162,467 $152,922 $145,534 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit by reportable segment and Corporate:
(in millions)202120202019
Pharmaceutical$1,684 $1,753 $1,834 
Medical577 663 576 
Total segment profit2,261 2,416 2,410 
Corporate(1,789)(6,514)(350)
Total operating earnings$472 $(4,098)$2,060 
Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment
The following tables present depreciation and amortization and additions to property and equipment by reportable segment and Corporate:
(in millions)202120202019
Pharmaceutical$151 $135 $147 
Medical226 243 288 
Corporate406 535 565 
Total depreciation and amortization$783 $913 $1,000 
(in millions)202120202019
Pharmaceutical$55 $47 $35 
Medical97 86 74 
Corporate248 242 219 
Total additions to property and equipment$400 $375 $328 
Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at June 30:
(in millions)202120202019
Pharmaceutical$23,624 $22,398 $22,446 
Medical (1)15,408 14,691 15,284 
Corporate5,421 3,677 3,233 
Total assets$44,453 $40,766 $40,963 
(1) Assets of $1.1 billion classified as held for sale related to the Cordis divestiture were included within Medical at June 30, 2021.
Property and Equipment, Net by Geographic Area
The following tables present property and equipment, net by geographic area:
(in millions)202120202019
United States$1,958 $1,880 $1,846 
International402 486 510 
Property and equipment, net$2,360 $2,366 $2,356